Listing 1 - 3 of 3 |
Sort by
|
Choose an application
Musculoskeletal disorders are a serious burden for patients and modern society. In Europe alone, 100,000,000 individuals suffer from musculoskeletal disorders and 40,000,000 affected workers cause losses due to work absence and a productivity loss of EUR 12 billion per year. Worldwide, musculoskeletal disorders are the second most common cause of pain and disability. Adequate diagnosis and early initiation of treatment are key elements in the care for patients suffering from musculoskeletal disorders, yet, for many musculoskeletal disorders, diagnostic tests lack appropriate accuracy. Treatment of musculoskeletal disorders is challenging as the mechanisms causing the complaints and mechanisms of action for the available treatment options are largely unknown. Moreover, these mechanisms and effectiveness might depend on specific patients’ characteristics and call for personalized strategies. This Special Issue invited researchers in the field to contribute to the state of the art in the diagnosis and treatment of musculoskeletal disorders. As many different healthcare professionals are involved in the diagnosis and treatment of musculoskeletal disorders, the Special Issue published high-quality studies from different areas of healthcare. Studies reporting on original research (e.g., randomized controlled trials, cohort studies), but also systematic literature reviews and meta-analyses within the scope of the Special Issue were considered. Given recent debates around the effectiveness of surgical interventions for musculoskeletal disorders and concomitant risks for adverse side-effects, intervention studies on non-surgical treatment options were prioritized.
osteoarthritis --- hip --- pain --- footwear --- case-crossover study --- musculoskeletal disorders --- therapeutic injections --- competence --- knee osteoarthritis --- radiography --- general practitioner --- secondary care physician --- diagnosis --- patellofemoral pain --- patellofemoral osteoarthritis --- pharmaceuticals --- nutraceuticals --- surgery --- long-term results --- adolescent idiopathic scoliosis --- skip pedicle fixation --- 10 years --- posterior fusion --- type 2 diabetes --- physical examination --- ultrasound --- shoulder pain --- adhesive capsulitis --- subacromial pain syndrome --- knee --- ACL --- injury --- KOOS --- symptoms --- knee pain --- early OA --- illness perceptions --- self-management strategies --- cross-sectional study --- survey --- femoral intercondylar notch --- knee anatomy --- ACL prevention --- ACL risk factors --- risk factor --- dance --- hypermobility --- lumbar radicular pain --- clinical practice guidelines --- AGREE II --- treatment
Choose an application
Musculoskeletal disorders are a serious burden for patients and modern society. In Europe alone, 100,000,000 individuals suffer from musculoskeletal disorders and 40,000,000 affected workers cause losses due to work absence and a productivity loss of EUR 12 billion per year. Worldwide, musculoskeletal disorders are the second most common cause of pain and disability. Adequate diagnosis and early initiation of treatment are key elements in the care for patients suffering from musculoskeletal disorders, yet, for many musculoskeletal disorders, diagnostic tests lack appropriate accuracy. Treatment of musculoskeletal disorders is challenging as the mechanisms causing the complaints and mechanisms of action for the available treatment options are largely unknown. Moreover, these mechanisms and effectiveness might depend on specific patients’ characteristics and call for personalized strategies. This Special Issue invited researchers in the field to contribute to the state of the art in the diagnosis and treatment of musculoskeletal disorders. As many different healthcare professionals are involved in the diagnosis and treatment of musculoskeletal disorders, the Special Issue published high-quality studies from different areas of healthcare. Studies reporting on original research (e.g., randomized controlled trials, cohort studies), but also systematic literature reviews and meta-analyses within the scope of the Special Issue were considered. Given recent debates around the effectiveness of surgical interventions for musculoskeletal disorders and concomitant risks for adverse side-effects, intervention studies on non-surgical treatment options were prioritized.
Medicine --- osteoarthritis --- hip --- pain --- footwear --- case-crossover study --- musculoskeletal disorders --- therapeutic injections --- competence --- knee osteoarthritis --- radiography --- general practitioner --- secondary care physician --- diagnosis --- patellofemoral pain --- patellofemoral osteoarthritis --- pharmaceuticals --- nutraceuticals --- surgery --- long-term results --- adolescent idiopathic scoliosis --- skip pedicle fixation --- 10 years --- posterior fusion --- type 2 diabetes --- physical examination --- ultrasound --- shoulder pain --- adhesive capsulitis --- subacromial pain syndrome --- knee --- ACL --- injury --- KOOS --- symptoms --- knee pain --- early OA --- illness perceptions --- self-management strategies --- cross-sectional study --- survey --- femoral intercondylar notch --- knee anatomy --- ACL prevention --- ACL risk factors --- risk factor --- dance --- hypermobility --- lumbar radicular pain --- clinical practice guidelines --- AGREE II --- treatment --- osteoarthritis --- hip --- pain --- footwear --- case-crossover study --- musculoskeletal disorders --- therapeutic injections --- competence --- knee osteoarthritis --- radiography --- general practitioner --- secondary care physician --- diagnosis --- patellofemoral pain --- patellofemoral osteoarthritis --- pharmaceuticals --- nutraceuticals --- surgery --- long-term results --- adolescent idiopathic scoliosis --- skip pedicle fixation --- 10 years --- posterior fusion --- type 2 diabetes --- physical examination --- ultrasound --- shoulder pain --- adhesive capsulitis --- subacromial pain syndrome --- knee --- ACL --- injury --- KOOS --- symptoms --- knee pain --- early OA --- illness perceptions --- self-management strategies --- cross-sectional study --- survey --- femoral intercondylar notch --- knee anatomy --- ACL prevention --- ACL risk factors --- risk factor --- dance --- hypermobility --- lumbar radicular pain --- clinical practice guidelines --- AGREE II --- treatment
Choose an application
Blindness and visual impairment impact significantly on an individual’s physical and mental well-being. Loss of vision is a global health problem, with approximately 250 million of the world’s population currently living with vision loss, of which 36 million are classified as blind. Visual impairment is more frequent in the elderly, with cataract and age-related macular degeneration (AMD) accounting for over 50% of cases globally. Oxidative stress has been strongly implicated in the pathogenesis of both conditions, and consequently the role of nutritional factors, in particular carotenoids and micronutrient antioxidants, have been investigated as possible preventative or therapeutic strategies. Dry eye syndrome (DES) is one of the most common ophthalmic conditions in the world. DES occurs where the eye does not produce enough tears and/or the tears evaporate too quicklyleading to discomfort and varying degrees of visual disturbance. There has recently been a great deal of interest in the potential for oral or topical supplementation with essential fatty acids (EFAs), specifically omega-3 and omega-6 fatty acids, as an adjunct to conventional treatments for DES. The objective of this Special Issue on ‘Nutrition and Eye Health’ is to publish papers describing the role of nutrition in maintaining eye health and the use of nutritional interventions to prevent or treat ocular disease. A particular (but not exclusive) emphasis will be on papers (reviews and/or clinical or experimental studies) relating to cataract, AMD and DES.
polyphenols --- n/a --- crocin --- chyrsin --- glaucoma --- dietary assessment --- photoreceptor degeneration --- dry eye --- RR-zeaxanthin --- nutritional supplements --- drug discovery --- corneal neovascularization (CNV) --- AMD --- dietary antioxidants --- micronutrients --- age-related macular degeneration --- preclinical models --- lenses --- microvascular lesions --- cyclooxigenase-2 (COX-2) --- angiogenesis --- fish oil --- macrophage --- anti-oxidant --- vascular endothelial growth factor (VEGF) --- rosmarinic acid --- visual cycle --- diabetic retinopathy --- lutein --- gut-retina axis --- light damage --- crocetin --- supplements --- clinical practice guidelines --- nutrition --- light --- eye disease --- dietary habits --- flavonoids --- phytoconstituents --- saffron --- carotenoids --- fatty acid --- electroretinography --- lens --- advanced glycation end products --- interleukin-1? (IL-1?) --- mesozeaxanthin (RS zeaxanthin) --- endoplasmic reticulum stress --- omega-3 polyunsaturated fatty acids --- clinical survey --- corneal chemical burn --- reduced glutathione --- omega-3 --- AGREE II --- retina --- inflammation --- anti-inflammatory --- retinal pigment epithelium --- diet --- Lactobacillus paracasei KW3110 --- Crocus Sativus L. --- saponins --- cataract --- CODS --- neoangiogenesis --- estrogen-deficient rats --- food frequency questionnaire --- gut microbiota --- antioxidant supplements --- sinapic acid --- personalised medicine --- systematic reviews --- nuclear factor-kappaB (NF-?B) --- diabetes --- Cucurbita argyrosperma --- oxidative stress --- endoplasmic reticulum
Listing 1 - 3 of 3 |
Sort by
|